OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 144 citing articles:

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Mérad, Jérôme C. Martin
Nature reviews. Immunology (2020) Vol. 20, Iss. 6, pp. 355-362
Open Access | Times Cited: 2356

Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Mouhamed Yazan Abou‐Ismail, Akiva Diamond, Sargam Kapoor, et al.
Thrombosis Research (2020) Vol. 194, pp. 101-115
Open Access | Times Cited: 644

COVID-19 length of hospital stay: a systematic review and data synthesis
Eleanor M. Rees, Emily Nightingale, Yalda Jafari, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 542

The many faces of the anti-COVID immune response
Santosha A. Vardhana, Jedd D. Wolchok
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 6
Open Access | Times Cited: 516

An immune-based biomarker signature is associated with mortality in COVID-19 patients
Michael S. Abers, Ottavia M. Delmonte, Emily Ricotta, et al.
JCI Insight (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 332

Mitochondria and microbiota dysfunction in COVID-19 pathogenesis
Jumana Saleh, Carole Peyssonnaux, Keshav K. Singh, et al.
Mitochondrion (2020) Vol. 54, pp. 1-7
Open Access | Times Cited: 293

Two distinct immunopathological profiles in autopsy lungs of COVID-19
Ronny Nienhold, Yari Ciani, Viktor H. Koelzer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 250

Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers
Youley Tjendra, Abdulaziz F. Al Mana, Andrea P. Espejo-Freire, et al.
Archives of Pathology & Laboratory Medicine (2020) Vol. 144, Iss. 12, pp. 1465-1474
Open Access | Times Cited: 240

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
Ana Copaescu, Olivia Smibert, Andrew Gibson, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 3, pp. 518-534.e1
Open Access | Times Cited: 229

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
Nicholas Murgolo, Alex G. Therien, Bonnie J. Howell, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 2, pp. e1009225-e1009225
Open Access | Times Cited: 204

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
Guillaume Carissimo, Weili Xu, Immanuel Kwok, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 165

Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
I Bernard, Daniel Limonta, Lara K. Mahal, et al.
Viruses (2020) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 160

COVID-19 length of hospital stay: a systematic review and data synthesis
Eleanor M. Rees, Emily Nightingale, Yalda Jafari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 141

Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention
John P. Hussman
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 139

Severe COVID-19 and aging: are monocytes the key?
Brandt D. Pence
GeroScience (2020) Vol. 42, Iss. 4, pp. 1051-1061
Open Access | Times Cited: 133

Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, et al.
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 2
Open Access | Times Cited: 129

Pathologic features of COVID-19: A concise review
Mohammadreza Tabary, Shaghayegh Khanmohammadi, Farnaz Araghi, et al.
Pathology - Research and Practice (2020) Vol. 216, Iss. 9, pp. 153097-153097
Open Access | Times Cited: 111

Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19
Bruce K. Patterson, Harish Seethamraju, Kush Dhody, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 97

A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients
Tania A. Khartabil, Henk Russcher, Ajam van der Ven, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 6, pp. 415-431
Open Access | Times Cited: 97

The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, et al.
Life Sciences (2020) Vol. 258, pp. 118166-118166
Open Access | Times Cited: 95

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Yun-yu Zhang, Bi-ru Li, Bo-tao Ning
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 94

Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19
Francesco De Virgiliis, Simone Di Giovanni
Nature Reviews Neurology (2020) Vol. 16, Iss. 11, pp. 645-652
Open Access | Times Cited: 88

Page 1 - Next Page

Scroll to top